Weed (BUDZ) Amortizatization of Intangibles (2022 - 2026)
Weed's (BUDZ) quarterly Amortizatization of Intangibles came in at $2564.0 in Q1 2026, little changed year-on-year from $2563.0 in Q1 2025, and little changed quarter-over-quarter from $2564.0 in Q4 2025.
Weed (BUDZ) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Weed's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $2564.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles changed 0.04% year-over-year to $2564.0 in Q1 2026; TTM through Mar 2026 was $10256.0, a 44.51% increase from a year earlier, with the FY2025 full-year figure at $10255.0, changed 0.0% from the prior year.
- Amortizatization of Intangibles was little changed at $2564.0 in Q1 2026 per BUDZ's latest filing, from $2564.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $47386.0 in Q2 2023 and bottomed at -$43094.0 in Q3 2023.
- The 5-year median for Amortizatization of Intangibles is $5621.0 (2024), against an average of $4364.3.
- Across the five-year window, Amortizatization of Intangibles surged 166.6% in 2023 and tumbled 165.43% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$15396.0 in 2022, then jumped by 166.6% to $10253.0 in 2023, then tumbled by 165.43% to -$6709.0 in 2024, then soared by 138.22% to $2564.0 in 2025, then changed by 0.0% to $2564.0 in 2026.
- Per Business Quant, the three latest BUDZ Amortizatization of Intangibles figures stand at $2564.0 (Q1 2026), $2564.0 (Q4 2025), and -$3552.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Weed | 3.10 Mn | 3.10 Mn | - | 2,564.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,564.00 |
| Mar 31, 2026 | 2,564.00 |
| Dec 31, 2025 | 2,564.00 |
| Dec 31, 2025 | 2,564.00 |
| Sep 30, 2025 | -3,552.00 |
| Sep 30, 2025 | -3,552.00 |
| Jun 30, 2025 | 8,680.00 |
| Jun 30, 2025 | 8,680.00 |
| Mar 31, 2025 | 2,563.00 |
| Mar 31, 2025 | 2,563.00 |
| Dec 31, 2024 | -6,709.00 |
| Dec 31, 2024 | -6,709.00 |
| Sep 30, 2024 | 5,621.00 |
| Sep 30, 2024 | 5,621.00 |
| Jun 30, 2024 | 5,622.00 |
| Jun 30, 2024 | 5,622.00 |
| Mar 31, 2024 | 5,721.00 |
| Mar 31, 2024 | 5,721.00 |
| Dec 31, 2023 | 10,253.00 |
| Dec 31, 2023 | 10,253.00 |